LYTIR

Insider · SEC Form 4 · Director, Chair, Scientific Advisory Brd

Wang Xiaodong

In the 12 months to Nov 8, 2026, on the open market: sold $46.8M of ONC. Filed a median of 2 business days after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $46.8M in total.Sep: Insider sales $24.7MOct: Insider sales $22.2MDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $46.8M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. ONCSold: BeOne Medicines Ltd. Oct 27, 2026 31,028 shares filed Oct 29, 2026 11 transactions 10b5-1 plan filing $11.3M
  2. ONCSold: BeOne Medicines Ltd. Oct 13, 2026 31,027 shares filed Oct 15, 2026 5 transactions 10b5-1 plan filing $10.9M
  3. ONCSold: BeOne Medicines Ltd. Sep 28, 2026 31,028 shares filed Sep 30, 2026 10 transactions 10b5-1 plan filing $11.3M
  4. ONCSold: BeOne Medicines Ltd. Sep 8, 2026 38,287 shares filed Sep 10, 2026 8 transactions 10b5-1 plan filing $13.4M

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.

Other Form 4 entries

Not counted above: entries this filer reported on Form 4 in the same 12 months that are not open-market purchases or sales. Each entry is one line of a filing.

  • ONC: option exercise or conversion (code M), 4 entries, Sep 8 to Oct 27, 2026
  • ONC: grant or award (code A), 1 entry, Jun 11, 2026
Code A
A grant or award from the company, such as stock given as pay.
Code M
An exercise or conversion of a derivative security received from the company, such as stock options.

Source: the same SEC Form 4 filings. The codes are the SEC's own transaction codes; the meanings above are a plain-words reading of the SEC's Form 4 instructions.